Combined melanocytic nevi are composed of 2 or more distinct populations of nevomelanocytes. Most commonly used to describe the combination of blue nevi with common nevi, it may also be applied to other combinations of benign melanocytic proliferations, including Spitz nevi and nevi with deep dermal pigmented nevomelanocytes. We report the incidence and distribution of these tumors at the Massachusetts General Hospital over the past decade and review guidelines for diagnostic criteria and nomenclature. Between 2000 and 2010 we identified 511 cases of combined nevi, represented by 4 histologically distinct diagnostic categories: (1) blue nevus, (2) nevi with deep dermal pigmented nevomelanocytes (plexiform/deep penetrating, inverted type A/clonal), (3) Spitz or pigmented spindled cell nevus, combined with another type of nevus (usually common or dysplastic), and (4) other combinations including 2 or more nevus types. Nearly one fifth of these tumors displayed atypical features; atypia was observed more often in combined nevi with Spitz or deep pigmented elements (26 of 55, 47%, and 25 of 98, 26%, respectively) than in combined common and blue nevi (37 of 336, 11%). Clinical follow-up data were available for 83% of the patients with atypical combined nevi; none developed recurrence or metastasis with a mean follow-up of over 4 years.
C ombined nevi are neoplasms composed of 2 or more distinct melanocytic populations. They comprise any melanocytic nevus, including blue nevus, Spitz nevus, or nevus with deep dermal pigmented cells, combined with another type of nevus, most often common acquired junctional, compound, dermal, congenital, lentiginous junctional dysplastic, or lentiginous compound dysplastic nevus.
The concept of combined nevus was first discussed in the French literature in 1906. 27 The first reported case of a common acquired nevus in combination with a blue nevus was described in 1912 10 but was not described in the English literature until 1953. 2 In 1962, Lund and Kraus 20 described "the admixture of a blue nevus with an ordinary pigmented nevus" as "the true and the blue." The specific term "combined nevus," in reference to a melanocytic nevus with 2 morphologic populations, was coined in 1967 by Leopold and Richards. 17, 18 Kernen and Ackerman 16 identified a separate intradermal nevus component in Spitz nevi, and later Weedon and Little 29 observed this combination in 32 of 211 spindled and epithelioid cell nevi also known as Spitz nevi. In 1977, Gartman and Muller 13 described in German patients combined nevi that displayed features of 2 or more of the following types of nevi: common nevus, blue nevus, cellular blue nevus, or Spitz nevus. In 1981, Fletcher and Sagebiel 12 reported 50 cases of combined nevi, and in 1985 Rogers et al 25 described a series of 22 combined Spitz nevi with a small cell nevic component. In 1991, Pulitzer et al 24 reported 95 cases, 15% of which had features of melanocytic dysplasia. In 2004, Scolyer et al 26 produced the largest series (182 cases), describing combined nevi as any combination of common and blue or Spitz nevus. In this series, deep penetrating nevus was considered as a type of blue nevus. In contrast, investigators have identified mutations in GNAQ in 83% of blue nevi (n = 29), without detection of these mutations in deep penetrating nevi (n = 16). 28 This finding may lead one to question whether deep penetrating nevi are blue nevus variants. In terms of site distribution, combined blue nevi have been described in the skin, oral mucosa, 11 and the conjunctiva. 8 In addition to combinations of common nevi with either a blue or Spitz nevic component, combined nevi have been described to include other uncommon nevi including clonal nevi (also known as inverted type A nevus), 23 atypical dermal nodule in benign melanocytic nevus, 6 melanocytic nevus with a focal atypical epithelioid cell component, 3 or deep penetrating (plexiform spindle cell) nevus, 7 all of which describe areas of dermal pigmented nevomelanocytes. This variability in types and in vernacular has led some to encourage the use of the term "combined nevi/melanocytic nevi with phenotypic heterogeneity" with the use of a descriptive qualifier. 4 The term "maturation" is used to describe cytologic distinctions of nevomelanocytes in the superficial dermis when compared with the deeper dermal nevomelanocytes. Superficially, pigmented epithelioid type A cells are observed. Slightly deeper are type B cells with smaller nuclei, less cytoplasm, and less pigmentation. Finally, at the deepest aspect of the nevus are type C cells with small round or fusiform nuclei and scant cytoplasm. This cytologic nevomelanocytic gradient in the dermis is characteristic of benign nevi. Combined nevi may appear to lack maturation because of the presence of 2 distinct populations of dermal nevomelanocytes. Cytologic atypia, mitoses, and foci of heavy pigmentation may also be present. 21, 24 Although combined nevi appear unusual, when the distinct subtypes of nevomelanocytes are recognized as such, they can be recognized as entirely benign. The term atypia is used when these melanocytic proliferations display features that may be observed in melanoma. Specifically, cytologic atypia is manifested by thickened nuclear membranes, clumped and asymmetrically dispersed nuclear chromatin, prominent nucleoli, and nuclear pleomorphism. In addition, the presence of mitotic activity is atypical in these tumors. The pattern of growth, including low-level epidermal pagetoid spread and an asymmetrical dermal silhouette at scanning magnification may also be considered to be atypical features in this setting. If unaware of the cytologic and architectural variation that may be found in these nevi, these characteristics may lead to overinterpretation and to the improper diagnosis of melanoma. Such a misdiagnosis is likely to prompt sentinel lymph node biopsy given the depth of these tumors. A familiarity with the diagnostic findings in combined nevi is critical to the optimal practice of dermatopathology.
MATERIALS AND METHODS
The electronic records of the Dermatopathology Unit in the James Homer Wright Laboratories of Pathology at the Massachusetts General Hospital were reviewed for cases that included both the terms "combined" and "nevus" in the final diagnosis field, between January 1, 2000 and January 1, 2010. A total of 540 cases were identified. Cases that represented a combination of a melanocytic nevus and an epithelial neoplasm were excluded. Overall, 511 cases of combined nevi composed of 2 or more distinct populations of nevomelanocytes have been diagnosed at the Massachusetts General Hospital (MGH) over the past decade. Review of reports and glass slides led to the identification of 4 distinct categories of tumors. The presence or absence and degree of atypical features were evaluated. Clinical followup information was obtained through the electronic medical record for patients with atypical combined nevi. This study was approved by the Partners Healthcare Institutional Review Board (2010P002328).
RESULTS
We identified 511 cases of combined nevi, including 59 consultations on slides from other institutions and 452 cases processed in the MGH Pathology Laboratory ( Table 1 ). Review of the cases revealed 4 histologically distinct diagnostic categories: (1) blue nevus, (2) nevus with deeply pigmented elements (inverted type A/clonal, deep penetrating/plexiform), or (3) Spitz or pigmented spindled cell nevus, combined with another distinct type of nevus (usually common or dysplastic), or (4) other combinations including combinations of 3 nevus types.
The most common type of combined nevus in this cohort was that combined with blue nevus; 66% of cases (336 of 511) received this diagnosis ( Table 1 ). Of these, 26 were consult cases (8%). The patients ranged from 4 to 86 years of age (mean, 47 y) and included slightly more female than male patients (179 F:158 M). Atypical features, such as cytologic atypia and mitotic activity, were identified in 11% (37 of 336) of cases. Thirty of the 37 patients with atypical nevi (81%) had available clinical Head and neck n = 3 (13%) Trunk n = 10 (45%) Extremities n = 7 (32%) Genital n = 2 (9%) Eye n = 0 (0%) follow-up data; none experienced recurrence or metastasis, with follow-up intervals ranging from 2 to 122 months (mean, 58 mo; median, 65 mo) ( Table 2) . The histologic features of nevi combined with blue nevi were the most benign appearing of all the subsets; thus, the differential diagnosis of melanoma was rarely a histologic consideration. The tumors were composed of nevomelanocytes that resembled 2 distinctly occurring benign nevi ( Fig. 1 ). All contained a component of blue nevus, manifested by a dermal proliferation of delicately dendritic, evenly pigmented nevomelanocytes with small, round-to-oval nuclei. Scattered melanin-laden macrophages were also present. The second nevomelanocytic population resembled either common or dysplastic nevi of dermal, junctional, or compound type. In cases with atypia, the atypical features most often represented cytologic atypia of the intraepidermal component of a dysplastic nevus. Mitoses were rarely, if ever, identified and did not exceed more than 1 or 2 per entire case. Significant epithelioid cytologic atypia of the dermal component was absent.
The second most common category of combined nevus, 19% of cases, included a component of pigmented epithelioid nevomelanocytes in the deep or mid-dermis. Of these 98 cases, 13 were consults (16%). The patients ranged in age from 4 to 79 years (mean, 40 y) and also included slightly more female than male patients (58 F:33 M) ( Table 1) . Atypical features were identified in 26% of cases (25 of 95). Twenty-one of these 25 patients (84%) had clinical follow-up available; none developed recurrence or metastasis, with follow-up intervals ranging from 0.3 to 126 months (mean, 59 mo; median, 58 mo) ( Table 2) .
This category of melanocytic nevi with a component of deep pigmentation could be segregated into 2 subcategories in most instances; however, some overlap was present in a few cases. The first subcategory was that of clonal or inverted type A nevus (73 of 98 cases). These benign melanocytic tumors characteristically contained a nested and individual cell proliferation of pigmented small epithelioid nevomelanocytes located in the middle or deep dermis in a focus distinct from that of the common nevus or dysplastic nevus elements (Fig. 2 ). These pigmented cells in some cases resembled the superficial pigmented cells (type A cells) observed in some common nevi. The presence of these pigmented cells in the dermis below a nonpigmented proliferation of type B or type C nevomelanocytes has led to the use of the term "inverted type A nevus." 23 In some cases, these distinct clone-like collections of pigmented cells were present in the more superficial or mid-dermis, in a pattern that suggested a separation of the cells from the background nevus; these cases have been described as "clonal nevi." 3 There is significant histologic overlap between inverted type A nevi and clonal nevi; we consider these terms to be synonymous. The second subcategory of combined nevi with deep pigmented epithelioid cells included those combined with deep penetrating nevus or plexiform spindled cell nevus (18 of 98 cases). In addition to a background of a common or dysplastic nevus, these cases contained a proliferation of delicately and lightly pigmented spindled cells or small epithelioid cells extending deep into the dermis along neurovascular bundles and adnexal structures ( Fig. 3 ). The oval nuclei of these cells characteristically have finely dispersed slightly hyperchromatic nuclear chromatin with small blue inconspicuous nucleoli and amphophilic to lightly pigmented cytoplasm. Neoplasms with an extension of these pigmented cells deep into the reticular dermis have been referred to as deep penetrating nevi. The term plexiform, alternatively, has been used to describe the characteristic dermal pattern that results from extension around neurovascular bundles. There is significant histologic overlap between deep penetrating nevi and plexiform spindled cell nevi; we consider these terms to be synonymous.
A minority of cases (7 of 98 cases) included a combination of both of the first 2 subcategories described above-for example, features of both inverted type A/ clonal and deep penetrating/plexiform nevus.
Both of these subcategories (clonal/inverted type A and deep penetrating/plexiform) are associated with variable numbers of pigment-laden macrophages, occasionally a sparse lymphocytic infiltrate, and most commonly a somewhat symmetrical dermal silhouette. More than a quarter of the 98 cases of combined nevi with pigmented epithelioid cells displayed atypical features. Some cases revealed significant variability in nevomelanocytic nuclear size, with large epithelioid cells containing prominent basophilic nucleoli. The presence of mitoses was also an atypical feature, although no more than 2 to 3 mitoses were identified in an entire case. Large size of the tumor, increased cellularity, and asymmetry at scanning magnification were also considered to be atypical features (Fig. 4) .
The third major category of combined nevi included those that displayed elements of Spitz nevus. These tumors were relatively rare, comprising 11% of the total cohort (55 cases 511). These cases included 5 children and 50 adults, with patient's ages ranging from 7 years to 76 years (mean, 35 y), and included more female than male patients (34 F:21 M) ( Table 1) . Combined nevi with Spitz elements were distinctive in that they contained a characteristic dermal proliferation of large epithelioid cells, more nested superficially and extending as individual cells between the deep reticular dermal collagen bundles, alongside a banal dermal or compound nevus, dysplastic nevus, or blue nevus ( Fig. 5 ). Of the 3 categories of combined nevi, atypia was observed most often in combined nevi with Spitz elements, occurring in nearly 50% of these tumors (26 of 55). Cytologic atypia, mitotic activity, nested large epithelioid cells at the base of the tumor, and infiltration of the deep dermis with increased cellularity were considered to be atypical features. In addition, the combination of an ordinary dermal Spitz nevus with a compound dysplastic nevus with cytologic atypia of the intraepidermal component was present in some cases. Twenty-three of the 26 patients (88%) had clinical follow-up; all 23 patients followed up were recurrence and metastasis free, with follow-up intervals ranging from 0.4 to 129 months (mean, 55 mo; median, 64 mo) ( Table 2) . In addition to these 3 principal categories of combined melanocytic nevi, a fourth category exists, encompassing those tumors with either combined elements of 3 or more types of nevi or manifesting as rare combinations of nevi, including nevi of special sites (genital or milk-line type) and pigmented epithelioid melanocytoma. These tumors represented <5% of the overall cohort of combined nevi (22 of 511) ( Table 1) .
Of the 96 atypical nevi identified across subtypes, 52 (54%) were reexcised. Of those reexcised, residual melanocytic tumor was identified in 20 cases (38%). Although most cases with residual nevus in the excision specimen had features similar to the combined nevus in the biopsy, melanoma in situ was identified in the reexcision of a case originally diagnosed as compound inverted type A with moderate-to-severe atypia. In addition, a severely atypical borderline tumor (depth 1.52 mm) was diagnosed on reexcision of a shave biopsy read as a superficial component of combined nevus and atypical spindled cell nevus with severe atypia. Finally, invasive melanoma (tumor thickness 0.5 mm) was identified in the reexcision specimen of a tumor diagnosed on biopsy as a combined spindled cell dermal nevus with severe atypia. Follow-up data were available for 80 of 96 patients with atypical features; no patient experienced local recurrence or metastases, with a follow-up time ranging from 0.3 to 129 months (mean, 56 mo), including the patient with an ultimate diagnosis of invasive melanoma on reexcision (the patient was disease free at 4 y) ( Table 2) . Although histologic features may allow for the distinction of combined nevi with atypia from melanoma in most cases, as noted above, such a distinction is not always possible, particularly when the biopsy represents a sample of a larger tumor. The 3 cases of residual/recurrent tumors that led to a later diagnosis of melanoma support the rationale that all combined nevi with atypia should be completely excised with free histologic margins.
DISCUSSION
Combined nevi are defined as those that display 2 or more distinct components of melanocytic nevi. These tumors may occur at any age and are slightly more common in women than in men. The clinical differential diagnosis often includes melanoma. The most common type of combined nevus is that combined with a blue nevus, and it is histologically distinctive. It is readily identified as benign and usually without any atypical findings. In contrast, those tumors with deeply pigmented or Spitz nevus elements often have atypical features. In these cases it is important to distinguish these tumors from melanoma.
Combined nevi are composed of at least 2 distinct populations of melanocytes, most commonly a blue nevus and a nevus with an intraepidermal component; the pathogenesis of these tumors is not known. Blue nevi consist of dendritic dermal melanocytes that may display Schwannian differentiation and have been proposed to be of neural origin. 22 Features that distinguish the melanocytes of blue nevi from neural cells include the presence of melanosomes with expression of the pigment-associated proteins detected by HMB-45, MART-1, and MelanA. In contrast, compound nevi are generally composed of epithelioid melanocytes with progressive loss of expression of pigment-associated proteins with increasing dermal depth of the tumor cells.
There are generally 2 hypotheses regarding the pathogenesis of the complex-combined melanocytic tumors: (1) these represent a hybrid of 2 coexisting disparate melanocytic tumors; and (2) the distinct cellular populations represent divergent terminal differentiation. 9 Recent embryological studies confirm the presence of 2 distinct pathways for the development and population of the skin by melanocytes. 1, 19 In this context it may be beneficial to hypothesize that dermal dendritic melanocytic tumors are derived from the neural (ventral) pathway of melanocytic development and that the common compound nevi and other types of nevi that may have an intraepidermal component are derived from the epithelial (dorsolateral) pathway. This hypothesis would support 2 distinct derivations of the tumor cells in combined nevi. In contrast, the observation that combined nevi are particularly prevalent on the eyelid and conjunctiva, and the apparent convergence of cytology in many cases of combined nevi, has been used to support the hypothesis of divergent terminal differentiation. 9, 26, 30 Combined nevi with deep dermal pigmented nevomelanocytes include a combination of variably termed melanocytic proliferations including inverted type A/ clonal nevi and plexiform/deep penetrating nevi, which are believed by some researchers to be variations of the same neoplasm. 2, 14, 15 There is general agreement that these nevi with deeply pigmented elements (inverted type A/clonal nevi and plexiform/deep penetrating nevi) are likely variants of blue nevi. Indeed, in their large cohort of combined nevi, Scolyer et al 26 included the deep penetrating nevi in the blue nevus category. We separated the blue nevi with a predominantly pigmented dendritic cell population from the inverted type A/clonal or plexiform/deep penetrating nevi because of the potential of these latter tumors for atypical features and the Combined Melanocytic Nevi frequency with which melanoma may be considered in the differential diagnosis. Combined nevi that have a component of inverted type A/clonal or plexiform/deep penetrating nevus are histologically the most complex and thus the most challenging diagnostically. The terms inverted type A and clonal are used interchangeably to describe nevi that contain a nested dermal melanocytic component with small cytologically banal pigmented epithelioid nevomelanocytes. The terms deep penetrating and plexiform are used interchangeably to describe nevi that contain a component of lightly pigmented epithelioid or spindled cells that extend deep into the dermis with a striking perivascular and perineural growth pattern. It is this latter growth pattern that has led to the descriptive term "plexiform." Approximately 25% of these cases will display significant atypia, manifested as cytologic atypia, mitotic activity, increased cellularity, loss of symmetry, or large size. These atypical and complex melanocytic proliferations must be histologically distinguished from melanoma. The intraepidermal and dermal growth patterns, stromal changes, cytologic features, and mitotic activity may all be helpful in this differential diagnosis.
When an intraepidermal component is present in combined nevi, it is usually a nested and lentiginous proliferation; pagetoid spread is rarely present. In cases with an intraepidermal proliferation that displays a prominent pagetoid growth pattern involving the upper epidermis, a diagnosis of melanoma is favored. The dermal growth pattern in combined nevi is usually symmetrical, with 2 or more distinct histologic subtypes of melanocytes, each composed of cytologically banalappearing nevomelanocytes forming nests and disposed as individual cells. The presence of tumor cells disposed as sheets or infiltrative cords of cytologically pleomorphic cells in the dermis, forming an asymmetrical profile at scanning magnification, supports the diagnosis of melanoma. Although the dermal collagen may have a sclerotic appearance in combined nevi, features such as the presence of regressive fibrosis or a desmoplastic stromal reaction are more commonly seen in melanoma. The sclerosis observed in combined nevi is associated with thickened collagen fibers, in contrast to the edematous fine dermal collagen fibers, ectatic blood vessels, and mononuclear infiltrate observed in regression. Desmoplastic stromal changes are associated with increased dermal hyaluronic acid (so-called connective tissue mucin). Finally, although considered by some to be subjective in interpretation, the cytologic features of the tumor cells may be of considerable help in distinguishing combined nevi from melanoma. In combined nevi there may be focal marked cytologic atypia of a few tumor cells; however, most of the cells have thin oval-to-round nuclear membranes with finely dispersed nuclear chromatin and rare macronucleoli. When macronucleoli are present, they are basophilic and round. In contrast, the tumor cells observed in melanoma have thickened irregularly contoured nuclear membranes, with clumped or uniformly opaque nuclear chromatin and eosinophilic macronucleoli that may be irregular in shape. Finally, although mitoses may rarely be observed in combined nevi, the presence of more than 3 mitoses in the dermal component, or the presence of atypical mitoses, supports a diagnosis of melanoma (Table 3) .
Although combined nevi with Spitz nevus are the rarest of the 3 types, significant atypical features are observed in nearly 50% of combined nevi that contain Spitz elements. Similar to that observed in the other variants, atypia may manifest as cytologic atypia, increased cellularity, loss of symmetry, or increase in the numbers of mitotic figures. An important histologic consideration in these cases is invasive melanoma, and a diligent search for deep dermal mitoses is warranted. In addition, combined nevi with Spitz elements may display dermal sclerosis, which may contribute to a differential diagnostic consideration of melanoma.
In summary, combined nevi are a diagnostic challenge when the distinct nevic components resemble melanoma. In a majority of cases, the distinction between melanoma and combined nevus can be made on the basis of the identification of the most common nevic subtypes, including common nevus with blue nevus, deeply pigmented nevus, or Spitz nevus components. In addition, some cytologic atypia is acceptable in these neoplasms, especially in the deep penetrating and Spitz types. There is little to no propensity for recurrence or metastasis following complete excision of the tumor; none of the 80 patients with atypical combined nevi for whom follow-up information was available developed recurrence or metastasis (mean follow-up of 55 to 59 mo for each subcategory), including 3 patients who underwent sentinel lymph node sampling. At the time that these tumors were diagnosed (more than 4 y ago), sentinel lymph node sampling was occasionally being performed as a diagnostic test in patients with markedly atypical melanocytic tumors. 5 At that time it was considered that metastases in a sentinel lymph node might be a better predictor of prognosis than the histologic findings in the primary tumor. Sentinel lymph node biopsy is not a recommended procedure in contemporary practice in the management of patients with atypical combined nevi. Complete excision of combined nevi with plexiform/deep penetrat-ing or Spitz elements and those that display atypical features is recommended; however, sentinel lymph node sampling is unlikely to be of benefit. If there is increased cellularity the lesion maintains a symmetrical nested, individual cell and/or plexiform growth pattern Sheet-like growth pattern or extending in an infiltrating manner into the subcutis and between collagen fibers with loss of overall symmetry Dermal fibrosis
Eosinophilic sclerosis may rarely be present Desmoplasia is rare Fibrosis with pigment-laden macrophages and regressive changes or desmoplastic stromal reaction may be present Mitoses
Rare, no more than 2 to 3 for the entire case May be absent or present in large numbers
